Inhibitory effect of vanillin-like compounds on respiration and growth of adenocarcinoma TA3 and its multiresistant variant TA3-MTX-R

European Journal of Pharmaceutical Sciences

Volumn 16, Issue 4-5, 2002, Pages 255-263

  Cordano, Gianni ^a   Pezoa, Jacqueline ^a   Muoz, Sergio ^a   Rivera, Enrique ^a   Medina, Jorge ^a   Núez Vergara, Luis J ^a   Pavani, Mario ^a   Guerrero, Aníbal ^a   Ferreira, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Amines; Imines; Mitochondria; Oxidative phosphorylation; Tumour cell lines; Vanillin

Indexed keywords

ADENOSINETRIPHOSPHATE; AMINES; CELLS; DERIVATIVES; ELECTRONS; SYNTHESIS (CHEMICAL); TUMORS;

PHOSPHORYLATIONS;

DRUG PRODUCTS;

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; METHOTREXATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UBIQUINONE; UNCOUPLING PROTEIN; VANILLIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREATHING; CANCER GROWTH; CELL LINE; CONTROLLED STUDY; DRUG INHIBITION; ELECTRON TRANSPORT; FETUS; LIVER CELL; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BENZALDEHYDES; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL DIVISION; CELL RESPIRATION; DRUG RESISTANCE, NEOPLASM; HEPATOCYTES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; TUMOR CELLS, CULTURED; UNCOUPLING AGENTS;

EID: 0036742431     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(02)00108-2     Document Type: Article

References (28)

1. Akagi K., Hirose M., Hoshiya T., Mizoguchi Y., Ito N., Shirai T. Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett. 94:1995;113-121.
2. Baggetto L. Role of mitochondria in carcinogenesis. Eur. J. Cancer. 29A:1 1993;156-159.
3. Cotton D., Rogers S. Ageing, cancer and mitochondrial deterioration. Lancet. 341:1993;156-159.
4. Fahrig R. Anti-mutagenic agents are also co-recombinogenic and can be converted into co-mutagens. Mutation Res. 350:1996;59-67.
5. Ferreira J., Gil L. Nutritional effects on mitochondrial bioenergetics. Alteration in oxidative phosphorylation by rat liver mitochondria. Biochem. J. 218:1984;61-67.
6. Floridi A., Barbieri R., Pulselli R., Fanciulli M., Arcuri E. Effect of the local anesthetic on the energy metabolism of Ehrlich ascites tumour cells. Oncol. Res. 6:1994;593-601.
7. Fones E., Amigo H., Gallegos K., Guerrero A., Ferreira J. t-Butyl-4-hydroxyanisole as an inhibitor of tumour cell respiration. Biochem. Pharmacol. 38:1989;3443-3451.
8. Hogman S. Prevention of cancer: vegetables and plants. Comp. Biochem. Physiol. 93B:1989;201-212.
9. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
10. Matsunaga T., Kudo J., Takahashi K., Domen K., Hayashida K., Okamura S., Ishibashi H., Niho Y. Rotenone, a mitochondrial NADH dehydrogenase inhibitor, induces cell surface expression of CD13 and CD38 and apoptosis in HL-60 cells. Leuk. Lymphoma. 20:1996;487-494.
11. Moldeus P., Hogberg J., Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52:1978;60-71.
12. Monod J., Changeux J.P., Jacob F. Allosteric proteins and cellular control systems. J. Mol. Biol. 6:1963;306-320.
13. Moreadith R.W., Fiskum G. Isolation of mitochondria from ascites tumour cells permeabilized with digitonin. Anal. Biochem. 137:1984;360-367.
14. Morello A., Pavani M., Garbarino J., Chamy M., Frey C., Mancilla J., Guerrero A., Repetto Y., Ferreira J. Effects and mode of action of 1,4-naphthoquinones isolated from Calceolaria sessilis on tumoural cells and Trypanosoma parasites. Comp. Biochem. Physiol. 112C:1995;119-128.
15. Pavani M., Fones E., Oksenberg D., Garcia M., Hernández C., Cordano G., Muñoz S., Mancilla J., Guerrero A., Ferreira J. Inhibition of tumoural cell respiration and growth by nordihydroguaiaretic acid. Biochem. Pharmacol. 48:1994;1935-1942.
16. Pedersen P. Tumour mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumour Res. 22:1978;190-274.
17. Penta J.S., Johnson F.M., Wachsman J.T., Copeland W.C. Mitochondrial DNA in human malignancy. Mutat. Res. 488:2001;119-133.
18. Pickard M., Kinsella A. Influence of both salvage and DNA damage response pathways on resistance to chemotherapeutic antimetabolites. Biochem. Pharmacol. 52:1996;425-431.
19. Rang H., Dale M. Pharmacology. 2nd Edition 1991;765-803 Churchill Livingstone New York.
20. Rodríguez-Enríquez S., Torres-Márquez M.A., Moreno-Sánchez R. Substrate oxidation and ATP supply in AS-30D hepatoma cells. Arch. Biochem. Biophys. 375:2000;21-30.
21. Sanyal R., Darrouti F., Parzefall M., Nagao M., Knasmuller S. Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis. 12:4 1997;297-303.
22. Satoh T., Miyoshi H., Sakamoto K., Iwamura H. Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases. Biochim. Biophys. Acta. 1273:1996;21-30.
23. Sawa T., Nakao M., Akaike T., Ono K., Maeda H. Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumour promoter effect of vegetables. J. Agric. Food Chem. 47:2 1999;397-402.
24. Shi L., Pardini R.S. Effect of NDGA on beef heart mitochondria and EMT6 mouse mammary carcinoma cells. Res. Commun. Mol. Pathol. Pharmacol. 90:1995;235-254.
25. Singh G., Moorehead R. Mitochondria as a target for combination cancer chemotherapy. Int. J. Oncol. 1:1992;825-829.
26. Tsuda H., Uehara N., Iwahori Y., Asamoto M., Iigo M., Nagao M., Matsumoto K., Ito M., Hirono I. Chemopreventive effects of β-carotene, α-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn. J. Cancer Res. 85:1994;1214-1219.
27. Wattenberg L. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. (Suppl.). 52:1992;2085s-2091s.
28. Wilkie D. Antimitochondrial drugs in cancer chemotherapy: preliminary communication. J. R. Soc. Med. 72:1979;599-601.